Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach

The present review assessed the evidence on risk factors for the occurrence of adverse health outcomes after discharge (i.e. unplanned readmission or adverse drug event after discharge) that are potentially modifiable by clinical pharmacist interventions. The findings were compared with patient char...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Morath, Benedict (VerfasserIn) , Wehran, Tanja (VerfasserIn) , Send, Alexander Francesco Josef (VerfasserIn) , Hoppe-Tichy, Torsten (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Seidling, Hanna (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 April 2017
In: British journal of clinical pharmacology
Year: 2017, Jahrgang: 83, Heft: 10, Pages: 2163-2178
ISSN:1365-2125
DOI:10.1111/bcp.13318
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1111/bcp.13318
Verlag, kostenfrei, Volltext: https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13318
Volltext
Verfasserangaben:Morath Benedict, Mayer Tanja, Send Alexander Francesco Josef, Hoppe‐Tichy Torsten, Haefeli Walter Emil, Seidling Hanna Marita

MARC

LEADER 00000caa a2200000 c 4500
001 1573997072
003 DE-627
005 20230427042849.0
007 cr uuu---uuuuu
008 180507s2017 xx |||||o 00| ||eng c
024 7 |a 10.1111/bcp.13318  |2 doi 
035 |a (DE-627)1573997072 
035 |a (DE-576)503997072 
035 |a (DE-599)BSZ503997072 
035 |a (OCoLC)1341008880 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Morath, Benedict  |d 1989-  |e VerfasserIn  |0 (DE-588)1158503830  |0 (DE-627)1020514639  |0 (DE-576)503996769  |4 aut 
245 1 0 |a Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions  |b a review with a systematic approach  |c Morath Benedict, Mayer Tanja, Send Alexander Francesco Josef, Hoppe‐Tichy Torsten, Haefeli Walter Emil, Seidling Hanna Marita 
264 1 |c 27 April 2017 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.05.2018 
520 |a The present review assessed the evidence on risk factors for the occurrence of adverse health outcomes after discharge (i.e. unplanned readmission or adverse drug event after discharge) that are potentially modifiable by clinical pharmacist interventions. The findings were compared with patient characteristics reported in guidelines that supposedly indicate a high risk of drug?related problems. First, guidelines and risk assessment tools were searched for patient characteristics indicating a high risk of drug?related problems. Second, a systematic PubMed search was conducted to identify risk factors significantly associated with adverse health outcomes after discharge that are potentially modifiable by a clinical pharmacist intervention. After the PubMed search, 37 studies were included, reporting 16 risk factors. Only seven of 34 patient characteristics mentioned in pertinent guidelines corresponded to one of these risk factors. Diabetes mellitus (n = 11), chronic obstructive lung disease (n = 9), obesity (n = 7), smoking (n = 5) and polypharmacy (n = 5) were the risk factors reported most frequently in the studies. Additionally, single studies also found associations of adverse health outcomes with different drug classes {e.g. warfarin [hazard ratio 1.50; odds ratio (OR) 3.52], furosemide [OR 2.25] or high beta?blocker starting doses [OR 3.10]}. Although several modifiable risk factors were found, many patient characteristics supposedly indicating a high risk of drug?related problems were not part of the assessed risk factors in the context of an increased risk of adverse health outcomes after discharge. Therefore, an obligatory set of modifiable patient characteristics should be created and implemented in future studies investigating the risk for adverse health outcomes after discharge. 
650 4 |a adverse drug events 
650 4 |a clinical pharmacy service 
650 4 |a hospital readmission 
650 4 |a risk factors 
700 1 |a Wehran, Tanja  |d 1990-  |e VerfasserIn  |0 (DE-588)1130812154  |0 (DE-627)885203291  |0 (DE-576)487026381  |4 aut 
700 1 |a Send, Alexander Francesco Josef  |d 1983-  |e VerfasserIn  |0 (DE-588)1076884539  |0 (DE-627)835432238  |0 (DE-576)44576676X  |4 aut 
700 1 |a Hoppe-Tichy, Torsten  |e VerfasserIn  |0 (DE-588)1095801376  |0 (DE-627)856418919  |0 (DE-576)467814597  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Seidling, Hanna  |d 1982-  |e VerfasserIn  |0 (DE-588)140696512  |0 (DE-627)703758861  |0 (DE-576)319591433  |4 aut 
773 0 8 |i Enthalten in  |t British journal of clinical pharmacology  |d Oxford : Wiley-Blackwell, 1974  |g 83(2017), 10, Seite 2163-2178  |h Online-Ressource  |w (DE-627)306585995  |w (DE-600)1498142-7  |w (DE-576)091140056  |x 1365-2125  |7 nnas  |a Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions a review with a systematic approach 
773 1 8 |g volume:83  |g year:2017  |g number:10  |g pages:2163-2178  |g extent:16  |a Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions a review with a systematic approach 
856 4 0 |u http://dx.doi.org/10.1111/bcp.13318  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13318  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180507 
993 |a Article 
994 |a 2017 
998 |g 140696512  |a Seidling, Hanna  |m 140696512:Seidling, Hanna  |d 910000  |d 910100  |e 910000PS140696512  |e 910100PS140696512  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1095801376  |a Hoppe-Tichy, Torsten  |m 1095801376:Hoppe-Tichy, Torsten  |d 910000  |d 910100  |e 910000PH1095801376  |e 910100PH1095801376  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1076884539  |a Send, Alexander Francesco Josef  |m 1076884539:Send, Alexander Francesco Josef  |d 910000  |d 910100  |e 910000PS1076884539  |e 910100PS1076884539  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1130812154  |a Wehran, Tanja  |m 1130812154:Wehran, Tanja  |d 910000  |d 910100  |e 910000PW1130812154  |e 910100PW1130812154  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1158503830  |a Morath, Benedict  |m 1158503830:Morath, Benedict  |d 910000  |d 910100  |e 910000PM1158503830  |e 910100PM1158503830  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1573997072  |e 3008058108 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"origin":[{"dateIssuedDisp":"27 April 2017","dateIssuedKey":"2017"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"16 S."}],"person":[{"role":"aut","display":"Morath, Benedict","given":"Benedict","family":"Morath","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Wehran, Tanja","given":"Tanja","family":"Wehran","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Send","given":"Alexander Francesco Josef","role":"aut","display":"Send, Alexander Francesco Josef"},{"display":"Hoppe-Tichy, Torsten","role":"aut","given":"Torsten","family":"Hoppe-Tichy","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Haefeli","given":"Walter E.","display":"Haefeli, Walter E.","role":"aut"},{"display":"Seidling, Hanna","role":"aut","given":"Hanna","roleDisplay":"VerfasserIn","family":"Seidling"}],"name":{"displayForm":["Morath Benedict, Mayer Tanja, Send Alexander Francesco Josef, Hoppe‐Tichy Torsten, Haefeli Walter Emil, Seidling Hanna Marita"]},"relHost":[{"titleAlt":[{"title":"BJCP"}],"pubHistory":["1.1974 -"],"recId":"306585995","title":[{"subtitle":"BJCP","title_sort":"British journal of clinical pharmacology","title":"British journal of clinical pharmacology"}],"id":{"issn":["1365-2125"],"eki":["306585995"],"doi":["10.1111/(ISSN)1365-2125"],"zdb":["1498142-7"]},"note":["Gesehen am 20.03.2014"],"disp":"Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions a review with a systematic approachBritish journal of clinical pharmacology","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"83(2017), 10, Seite 2163-2178","issue":"10","volume":"83","year":"2017","extent":"16","pages":"2163-2178"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford ; Oxford ; Oxford [u.a.]","dateIssuedKey":"1974","dateIssuedDisp":"1974-"}],"language":["eng"]}],"id":{"doi":["10.1111/bcp.13318"],"eki":["1573997072"]},"title":[{"subtitle":"a review with a systematic approach","title":"Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions","title_sort":"Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions"}],"recId":"1573997072","note":["Gesehen am 07.05.2018"]} 
SRT |a MORATHBENERISKFACTOR2720